Industry News
Discovery Of First Major Genetic Mutation Associated With Hereditary Prostate Cancer Risk
Jan 13, 2012
After a 20-year quest to find a genetic driver for prostate cancer that strikes men at younger ages and runs in families, researchers have identified a rare, inherited mutation linked to a significantly higher risk of the disease. A report on the discovery was published in the January 12, 2012 issue of the New England Journal of Medicine... Read More
Leukemia Relapse May Be Influenced By Chemotherapy
Jan 13, 2012
The chemotherapy drugs required to push a common form of adult leukemia into remission may contribute to DNA damage that can lead to a relapse of the disease in some patients, findings of a new study suggest. The research, by a team of physicians and scientists at Washington University School of Medicine in St. Louis, is published in the advance online edition of Nature... Read More
Potential Approaches To Combat Aggressive Leukemia Identified By Cancer Sequencing Project
Jan 13, 2012
St... Read More
Gene Identified As A New Target For Treatment Of Aggressive Childhood Eye Tumor
Jan 13, 2012
St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project findings help solve mystery of retinoblastoma's rapid growth in work that also yields a new treatment target and possible therapy New findings from the St... Read More
Further Investigation Needed To Understand Link Between Parabens And Breast Cancer
Jan 13, 2012
New research into the potential link between parabens and breast cancer has found traces of the chemicals in breast tissue samples from all of the women in the study. Parabens are commonly used as preservatives in cosmetics, food products and pharmaceuticals... Read More
Early-Stage Non-Small Cell Lung Cancer - Malignancy Gene Signature Found
Jan 12, 2012
According to an investigation published in the recent issue of the Journal of the National Cancer Institute, researchers at Moffitt Cancer Center in Tampa, Florida have discovered that a malignancy-risk gene signature created for breast cancer has predictive and prognostic value for individuals suffering with early stage non-small cell lung cancer (NSCLC)... Read More
Does Race And Gender Play Role? Obesity And Cancer Screening
Jan 12, 2012
According to a recent study by researchers in Family and Community Medicine at the Thomas Jefferson University published in the current issue of the Journal of Obesity, obesity is associated with higher rates of prostate cancer screening amongst all races and ethnic differences as well as lower rates of cervical cancer screening predominantly in white women... Read More
A Plan To Effectively Treat Psoriasis
Jan 12, 2012
About 300 000 Swedes suffer from the difficult to treat disease, which manifests itself in scaly and often itchy patches on the skin. The reason is that cells divide without restraint as new blood vessels form in the deeper layers of the skin. An important component is the psoriasin protein (S100A7), which are abundant in psoriasis-affected skin but rarely in normal skin... Read More
Tapping The Body's Own Defenses, Researchers Look To Cutting-Edge Gene Therapy For Bladder Cancer
Jan 12, 2012
Bladder cancer, most frequently caused by smoking and exposure to carcinogens in the workplace, is one of the top 10 most common forms of cancer in men and women in the U.S. More than 70 percent of bladder cancers are diagnosed in stage T1 or less and have not invaded the muscle layer... Read More
Major Advance In Understanding The Regulation Of An Important Cancer Target
Jan 12, 2012
Scientists at the University of Leicester have opened up a whole new approach to the therapeutic intervention for a family of anti-cancer drug targets, thanks to a completely new and unexpected finding... Read More
Previous Page Next Page